I think this is great news - an uber well-respected scientist with extensive contacts in the finance world and large biotech/pharma. If he can't open doors, I don't know who can. Although this doesn't fulfill my request for publication in respected journals to validate the company's technology, it's pretty darn close. If it's good enough for Rosenblatt, then it's good enough for me. One more risk mitigated.
I'll admit it, I've trashed-talked PYC on occasions. At the time I was right. Now it seems that Rohan has got this thing firmly under control.
Ann: PYC Appoints US Biotech Veteran to its Board of Directors, page-12
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.15 |
Change
0.020(1.77%) |
Mkt cap ! $670.7M | |||
| Open | High | Low | Value | Volume |
| $1.15 | $1.18 | $1.11 | $172.3K | 151.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 592 | $1.15 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.16 | 4211 | 1 |
View Market Depth
| Last trade - 16.10pm 20/06/2025 (20 minute delay) ? |
| PYC (ASX) Chart |